Literature DB >> 16243493

Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder.

Pnina Green1, Haggai Hermesh, Assaf Monselise, Sofi Marom, Gadi Presburger, Abraham Weizman.   

Abstract

The "phospholipid hypothesis" attributes a pathophysiologic role to the polyunsaturated fatty acid (PUFA) composition of phospholipids in depression. The aim of the present study was to determine whether the hypothesis is relevant to social anxiety disorder (SAD). The study sample consisted of 27 untreated, nondepressed patients with SAD (DSM-IV) and 22 controls. Severity of SAD was assessed with the Liebowitz Social Anxiety Scale (LSAS). Erythrocyte PUFA concentrations were measured by gas-liquid chromatography. Concentrations of most n-3 PUFAs were lower in the patients: 18:3n-3 by 32% (p < 0.002), 20:3n-3 by 34%, 20:5n-3 by 36% (all p < 0.001) and 22:6n-3 by 18% (p = 0.002). No significant differences were observed in other fatty acids. Significant inverse correlations were obtained between levels of n-3 PUFAs and LSAS scores. In conclusion, the phospholipid hypothesis may apply to SAD, thereby opening new therapeutic options. The robust relationship between low erythrocyte n-3 PUFA concentrations and SAD justifies exploration of relevant neuropathophysiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243493     DOI: 10.1016/j.euroneuro.2005.07.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  37 in total

1.  Fish consumption among pregnant women in London, Ontario: associations with socio-demographic and health and lifestyle factors.

Authors:  Jessica M Sontrop; M Karen Campbell; Susan E Evers; Kathy N Speechley; William R Avison
Journal:  Can J Public Health       Date:  2007 Sep-Oct

2.  Particle formation and characterization of mackerel reaction oil by gas saturated solution process.

Authors:  A S M Tanbirul Haque; Byung-Soo Chun
Journal:  J Food Sci Technol       Date:  2015-08-28       Impact factor: 2.701

3.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

4.  Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study.

Authors:  Almudena Sanchez-Villegas; Patricia Henríquez; Adolfo Figueiras; Felipe Ortuño; Francisca Lahortiga; Miguel A Martínez-González
Journal:  Eur J Nutr       Date:  2007-08-23       Impact factor: 5.614

Review 5.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

Review 6.  Omega-3 Supplementation for Psychotic Mania and Comorbid Anxiety in Children.

Authors:  Anthony T Vesco; Jennifer Lehmann; Barbara L Gracious; L Eugene Arnold; Andrea S Young; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-08-19       Impact factor: 2.576

7.  Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids.

Authors:  Joseph R Hibbeln; John M Davis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-07-19       Impact factor: 4.006

8.  Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors:  Robert K McNamara; Jeffrey R Strawn
Journal:  PharmaNutrition       Date:  2013-04

9.  Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers.

Authors:  Laure Buydens-Branchey; Marc Branchey; Joseph R Hibbeln
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-11-01       Impact factor: 5.067

10.  Modulation of fear memory by dietary polyunsaturated fatty acids via cannabinoid receptors.

Authors:  Daisuke Yamada; Jiro Takeo; Peter Koppensteiner; Keiji Wada; Masayuki Sekiguchi
Journal:  Neuropsychopharmacology       Date:  2014-02-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.